Open AccessDecreased effect of glucantime in cutaneous leishmaniasis complicated with secondary bacterial infection
Author(s) -
G Sadeghian,
Hengameh Ziaei,
LShirani Bidabadi,
Azadeh Zolfaghari Baghbaderani
Publication year - 2011
Publication title -
indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/0019-5154.77549
Subject(s) - medicine , cutaneous leishmaniasis , leishmaniasis , microbiological culture , gastroenterology , group b , dermatology , immunology , bacteria , biology , genetics
Glucantime is regarded as the first-line treatment of cutaneous leishmaniasis (CL); however, failure to treatment is a problem in many cases.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom